Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-02

Clinical Trial Update: Vaginal Sildenafil for Primary Dysmenorrhea [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating vaginal sildenafil for primary dysmenorrhea is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vaginal sildenafil (sildenafil)

Snippet

Sponsor: Kevin Hellman | Conditions: Dysmenorrhea, Menstrual Pain | Phase 1 | Status: NOT_YET_RECRUITING